0
No votes yet
Online Exclusive Article

Improving the Safety of Chemotherapy Administration: An Oncology Nurse-Led Failure Mode and Effects Analysis

Laura Ashley
Rachel Dexter
Fay Marshall
Brenda McKenzie
Maggie Ryan
Gerry Armitage
ONF 2011, 38(6), E436-E444 DOI: 10.1188/11.ONF.E436-E444

Purpose/Objectives: To assess and improve the safety of hospital-based adult chemotherapy administration.

Design: Prospective, systems-focused clinical risk assessment.

Setting: An adult inpatient and outpatient oncology unit in a large urban hospital in the United Kingdom.

Sample: 8-person nurse-led multidisciplinary team, which included managerial staff and patient safety researchers.

Methods: Failure mode and effects analysis (FMEA), a prospective, systems-focused risk assessment methodology, was undertaken in biweekly team meetings and included mapping the chemotherapy administration process, identifying and numerically prioritizing potential errors (failure modes) for each process step, and generating remedial strategies to counteract them.

Main Research Variables: The analysis aimed to identify chemotherapy administration failure modes and to generate remedial strategies to address them. User feedback on the FMEA process also was collected.

Findings: Several specific chemotherapy failure modes were identified, the majority of which had not previously been recognized, and several novel strategies to counteract them were generated. Many of the strategies were specific, environment-focused actions, which are simple, quick, and inexpensive to implement; however, more substantive, longer-term initiatives also were generated. User feedback generally was very positive, and the process of undertaking the analysis improved multidisciplinary teamwork and communication.

Conclusions: Although time and resource intensive, FMEA is a useful safety improvement tool.

Implications for Nursing: Nurses should be aware of and informed about FMEA as a tool they can use in partnership with management and other disciplines to proactively and collectively improve the safety of high-risk oncology procedures such as chemotherapy administration.

References 

Adachi, W., & Lodolce, A.E. (2005). Use of failure mode and effects analysis in improving the safety of IV drug administration. <i>American Journal of Health System Pharmacy, 62</i>, 917-920.

Apkon, M., Leonard, J., Probst, L., DeLizio, L., & Vitale, R. (2004). Design of a safer approach to intravenous drug infusions: Failure mode effects analysis. <i>Quality and Safety in Health Care, 13</i>, 265-271. doi:10.1136/qshc.2003.007443

Ashley, L., & Armitage, G. (2010). Failure mode and effects analysis: An empirical comparison of failure mode scoring procedures. <i>Journal of Patient Safety, 6</i>, 210-215. doi:10.1097/PTS.0b013e3181fc98d7

Ashley, L., Armitage, G., Neary, M., & Hollingsworth, G. (2010). A practical guide to failure mode and effects analysis in health care: Making the most of the team and its meetings. <i>Joint Commission Journal on Quality Patient Safety, 36</i>, 351-358.

Beyer, M., Rohe, J., Nicklin, P.J., & Haynes, K. (2007). Communication and patient safety. In J. Sandars & G. Cook (Eds.), <i>ABC of patient safety</i> (pp. 16-19). Oxford, England: Blackwell.

Bonfant, G., Belfanti, P., Paternoster, G., Gabrielli, D., Gaiter, A.M., Manes, M., … Nebiolo, P.E. (2010). Clinical risk analysis with failure mode and effect analysis (FMEA) model in a dialysis unit. <i>Journal of Nephrology, 23</i>, 111-118.

Bonnabry, P., Cingria, L., Ackermann, M., Sadeghipour, F., Bigler, L., & Mach, N. (2006). Use of a prospective risk analysis method to improve the safety of the cancer chemotherapy process. <i>International Journal for Quality in Health Care, 18</i>, 9-16. doi:10.1093/intqhc/mzi082

Burgmeier, J. (2002). Failure mode and effect analysis: An application in reducing risk in blood transfusion. <i>Joint Commission Journal on Quality and Patient Safety, 28</i>, 331-339.

Chan, D.T.M., Ng, S.S.M., Chong, Y.H., Wong, J., Tam, Y.H., Lam, Y.H., … Lai, P. (2010). Using "failure mode and effects analysis" to design a surgical safety checklist for safer surgery. <i>Surgical Practice, 14</i>(2), 53-60. doi:10.1111/j.1744-1633.2010.00494.x

Chiozza, M.L., & Ponzetti, C. (2009). FMEA: A model for reducing medical errors. <i>Clinica Chimica Acta, 404</i>, 75-78. doi:10.1016/j.cca.2009.03.015

Christian, C.K., Gustafson, M.L., Roth, E.M., Sheridan, T.B., Gandhi, T.K., Dwyer, K., … Dierks, M.M. (2006). A prospective study of patient safety in the operating room. <i>Surgery, 139</i>, 159-173. doi:10.1016/j.surg.2005.07.037

Cohen, M.R., Senders, J., & Davis, N.M. (1994). Failure mode and effects analysis: A novel approach to avoiding dangerous medication errors and accidents. <i>Hospital Pharmacy, 29</i>, 319-330.

Cousins, D.H., & Upton, D.R. (1994). Chemotherapy errors can kill. <i>Hospital Pharmacy Practice, 4</i>, 311-312.

Day, S., Dalto, J., Fox, J., Allen, A., & Ilstrup, S. (2007). Utilization of failure mode effects analysis in trauma patient registration. <i>Quality Management in Health Care, 16</i>, 342-348.

DeRosier, J., Stalhandske, E., Bagian, J.P., & Nudell, T. (2002). Using Health Care Failure Mode and Effect Analysis™: The VA National Center for Patient Safety's prospective risk analysis system. <i>Joint Commission Journal on Quality and Patient Safety, 28</i>, 248-267.

Esmail, R., Cummings, C., Dersch, D., Duchscherer, G., Glowa, J., Liggett, G., & Hulme, T. (2005). Using healthcare failure mode and effect analysis tool to review the process of ordering and administering potassium chloride and potassium phosphate. <i>Healthcare Quarterly, 8</i>, 73-80.

Firth-Cozens, J., & Sandars, J. (2007). The nature of error. In J. Sandars & G. Cook (Eds.), <i>ABC of patient safety</i> (pp. 4-8). Oxford, England: Blackwell Publishing.

Ford, E.C., Gaudette, R., Myers, L., Vanderver, B., Engineer, L., Zellars, R., … Deweese, T.L. (2009). Evaluation of safety in a radiation oncology setting using failure mode and effects analysis. <i>International Journal of Radiation Oncology, Biology, Physics, 74</i>, 852-858. doi:10.1016/j.ijrobp.2008.10.038

Frankel, A., Graydon-Baker, E., Neppl, C., Simmonds, T., Gustafson, M., & Gandhi, T.K. (2003). Patient Safety Leadership WalkRounds™. <i>Joint Commission Journal on Quality and Patient Safety, 29</i>, 16-26.

Frankel, A., Grillo, S.P., Baker, E.G., Huber, C.N., Abookire, S., Grenham, M., … Gandhi, T.K. (2005). Patient Safety Leadership WalkRounds™ at Partners Healthcare: Learning from implementation. <i>Joint Commission Journal on Quality and Patient Safety, 31</i>, 423-437.

Gandhi, T.K., Bartel, S.B., Shulman, L.N., Verrier, D., Burdick, E., Cleary, A., … Bates, D.W. (2005). Medication safety in the ambulatory chemotherapy setting. <i>Cancer, 104</i>, 2477-2483. doi:10.1002/cncr.21442

Habraken, M.M.P., Van der Schaaf, T.W., Leistikow, I.P., & Reijnders-Thijssen, P.M.J. (2009). Prospective risk analysis of healthcare processes: A systematic evaluation of the use of HFMEA™ in Dutch health care. <i>Ergonomics, 52</i>, 809-819. doi:10.1080/00140130802578563

Institute for Safe Medication Practices. (2001). <i>Failure mode and effects analysis can help guide error prevention efforts</i>. Retrieved from <a target="_blank" href='http://www.ismp.org/Newsletters/acutecare/articles/20011017.asp'>http://...

Institute for Safe Medication Practices. (2008). <i>ISMP's list of high-alert medications</i>. Retrieved from <a target="_blank" href='http://www.ismp.org/Tools/highalertmedications.pdf'>http://www.ismp.org/...

Institute of Medicine. (2000). <i>To err is human: Building a safer health system</i>. Washington, DC: National Academies Press.

Kim, G.R., Chen, A.R., Arceci, R.J., Mitchell, S.H., Kokoszka, K.M., Daniel, D., & Lehmann, C.U. (2006). Error reduction in paediatric chemotherapy: Computerized order entry and failure modes and effects analysis. <i>Archives of Pediatrics and Adolescent Medicine, 160</i>, 495-498. doi:10.1001/archpedi.160.5.495

Kimchi-Woods, J., & Shultz, J.P. (2006). Using HFMEA to assess potential for patient harm from tubing misconnections. <i>Joint Commission Journal on Quality and Patient Safety, 32</i>, 373-381.

Kozakiewicz, J.M., Benis, L.J., Fisher, S.M., & Marseglia, J.B. (2005). Safe chemotherapy administration: Using failure mode and effects analysis in computerized prescriber order entry. <i>American Journal of Health-System Pharmacy, 62</i>, 1813-1816. doi:10.2146/ajhp040553

Linkin, D.R., Sausman, C., Santos, L., Lyons, C., Fox, C., Aumiller, L., … Lautenbach, E. (2005). Applicability of healthcare failure mode and effects analysis to healthcare epidemiology: Evaluation of the sterilization and use of surgical instruments. <i>Clinical Infectious Diseases, 41</i>, 1014-1019. doi:10.1086/433190

National Chemotherapy Advisory Group. (2009). <i>Chemotherapy services in England: Ensuring quality and safety</i>. Retrieved from <a target="_blank" href='http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/di...

National Patient Safety Agency. (2004). Seven steps to patient safety: The full reference guide. Retrieved from <a target="_blank" href='http://www.nrls.npsa.nhs.uk/resources/collections/seven-steps-to-patient...

Paparella, S. (2007). Failure mode and effects analysis: A useful tool for risk identification and injury prevention. <i>Journal of Emergency Nursing, 33</i>, 367-371. doi:10.1016/j.jen.2007.03.009

Reason, J. (2000). Human error: Models and management. <i>BMJ, 320</i>, 768-770. doi:10.1136/bmj.320.7237.768

Reason, J. (2004). Beyond the organizational accident: The need for "error wisdom" on the frontline. <i>Quality and Safety in Health Care, 13</i>(Suppl. II), II28-II33. doi:10.1136/qshc.2003.009548

Rivera-Rodriguez, A.J., & Karsh, B.T. (2010). Interruptions and distractions in healthcare: Review and reappraisal. <i>Quality and Safety in Health Care, 19</i>, 304-312. doi:10.1136/qshc.2009.033282

Robinson, D.L., Heigham, M., & Clark, J. (2006). Using failure mode and effects analysis for safe administration of chemotherapy to hospitalized children with cancer. <i>Joint Commission Journal on Quality Patient Safety, 32</i>, 161-166.

Senders, J.W. (2004). FMEA and RCA: The mantras of modern risk management. <i>Quality and Safety in Health Care, 13</i>, 249-250. doi:10.1136/qshc.2004.010868

Shebl, N.A., Franklin, B.D., & Barber, N. (2009). Is failure mode and effect analysis reliable? <i>Journal of Patient Safety, 5</i>, 86-94. doi:10.1097/PTS.0b013e3181a6f040

Sheridan-Leos, N., Schulmeister, L., & Hartranft, S. (2006). Failure mode and effect analysis: A technique to prevent chemotherapy errors. <i>Clinical Journal of Oncology Nursing, 10</i>, 393-398. doi:10.1188/06.CJON.393-398

Smith, A., Boult, M., Woods, I., & Johnson, S. (2010). Promoting patient safety through prospective risk identification: Example from perioperative care. <i>Quality and Safety in Health Care, 19</i>, 69-73. doi:10.1136/qshc.2008.028050

Spath, P.L. (2003). Home study program: Using failure mode and effects analysis to improve patient safety. <i>AORN Journal, 78</i>, 16-37. doi:10.1016/S0001-2092(06)61343-4

Stalhandske, E., DeRosier, J., Patail, B., & Gosbee, J. (2003). How to make the most of failure mode and effect analysis. <i>Biomedical Instrumentation and Technology, 37</i>, 96-102. doi:10.2345/0899-8205 (2003)37[96:HTMTMO]2.0.CO;2

Steinberger, D.M., Douglas, S.V., & Kirschbaum, M.S. (2009). Use of failure mode and effects analysis for proactive identification of communication and handoff failures from organ procurement to transplantation. <i>Progress in Transplantation, 19</i>, 208-214.

Summerhayes, M. (2003). The impact of workload changes and staff availability on IV chemotherapy services. <i>Journal of Oncology Pharmacy Practice, 9</i>, 123-128. doi:10.1191/1078155203jp112oa

Trinkle, R., & Wu, J.K. (1996). Errors involving pediatric patients receiving chemotherapy: A literature review. <i>Medical and Pediatric Oncology, 26</i>, 344-351. doi:10.1002/(SICI)1096-911X(199605)26:5<344::AID-MPO7>3.0.CO;2-I

Van Tilburg, C.M., Leistikow, I.P., Rademaker, C.M.A., Bierings, M.B., & van Dijk, A.T.H. (2006). Health care failure mode and effect analysis: A useful proactive risk analysis in a pediatric oncology ward. <i>Quality and Safety in Health Care, 15</i>, 58-64. doi:10.1136/qshc.2005.014902

Verity, R., Wiseman, T., Ream, E., Teasdale, E., & Richardson, A. (2008). Exploring the work of nurses who administer chemotherapy. <i>European Journal of Oncology Nursing, 12</i>, 244-252. doi:10.1016/j.ejon.2008.02.001

Vincent, C. (2006). <i>Patient safety</i>. London, England: Elsevier.

Walsh, K.E., Dodd, K.S., Seetharaman, K., Roblin, D.W., Herrinton, L.J., Von Worley, A., … Gurwitz, J.H. (2009). Medication errors among adults and children with cancer in the outpatient setting. <i>Journal of Clinical Oncology, 27</i>, 891-896. doi:10.1200/JCO.2008.18.6072

Weingart, S.N., Toro, J., Spencer, J., Duncombe, D., Gross, A., Bartel, S., … Connor, M. (2010). Medication errors involving oral chemotherapy. <i>Cancer, 116</i>, 2455-2464.

Wetterneck, T.B., Skibinski, K.A., Roberts, T.L., Kleppin, S.M., Schroeder, M.E., Enloe, M., … Carayon, P. (2006). Using failure mode and effects analysis to plan implementation of smart IV pump technology. <i>American Journal of Health-System Pharmacy, 63</i>, 1528-1538. doi:10.2146/ajhp050515